Ibex Ltd director sells over $380k in company stock

In a recent transaction, Mohammedulla Khaishgi, a director at IBEX Ltd (NASDAQ:IBEX ), sold a significant number of shares in the company. Investors took note as the director disposed of shares in two separate transactions dated September 19 and September 20.

On September 19, Khaishgi sold a total of 7,417 common shares at a price of $20.00 per share. The following day, he continued to reduce his position by selling an additional 11,699 shares. These sales were executed in multiple trades with prices ranging from $20.00 to $20.05, with the reported prices reflecting the weighted average sales price.

The total value of the shares sold by Khaishgi amounted to approximately $382,337. This series of transactions has caught the attention of the market, as it represents a notable change in the director's stake in the company.

Following these transactions, Khaishgi still holds a significant number of shares in IBEX Ltd, both directly and indirectly as a trustee of the Allibhoy Khaishgi Family Foundation. The direct holdings amount to 296,711 shares, while the indirect holdings through the foundation total 122,399 shares.

Investors and analysts often monitor insider sales as they may provide insights into a director's perspective on the company's current valuation and future prospects. However, it is also common for insiders to sell shares for reasons that may not necessarily reflect their outlook on the company, such as personal financial planning or diversifying their investment portfolio.

The transactions were reported in a Form 4 filing with the U.S. Securities and Exchange Commission, with Lisa Lenstrohm, Attorney-in-Fact, signing off on the document on September 20, 2024.



In other recent news, financial services firm Baird has raised its price target for IBEX Ltd. from $20 to $23, maintaining an Outperform rating, following a positive outlook on the company's potential. This comes after IBEX reported a transformative year with a record increase in earnings per share (EPS) to $2.10 and a rise in free cash flow to $27 million. Despite a slight annual revenue decrease to $509 million, the company's fourth-quarter revenue indicated a return to growth.

Simultaneously, RBC Capital Markets upgraded its price target for IBEX from $18 to $20, keeping a Sector Perform rating. This adjustment followed IBEX's announcement of a return to revenue growth, marking a 1% year-over-year increase in the last quarter. These developments underscore the positive trajectory of IBEX's financial performance.

In addition to these developments, Baird's analysis highlighted that IBEX's revenue, EBITDA, and EPS for the quarter surpassed Wall Street's expectations. The firm also noted the company's aspirations to achieve 5-7% revenue growth and 15% EBITDA margins over time, with artificial intelligence playing a significant role in driving these margin expansion opportunities. These are recent developments, and investors should keep an eye on IBEX's continued performance.
InvestingPro Insights


Amid the recent insider sales at IBEX Ltd, current and potential investors may find it worthwhile to consider key financial indicators and metrics that provide a broader context for the company's performance and valuation. Here are some pertinent data and tips from InvestingPro:

The market capitalization of IBEX Ltd stands at $335.9 million, reflecting the market's valuation of the company. With a P/E ratio of 10.51 and an adjusted P/E ratio for the last twelve months as of Q4 2024 at 9.29, IBEX Ltd is trading at a low earnings multiple relative to near-term earnings growth. This could suggest that the company's stock is undervalued compared to its earnings potential.

Moreover, IBEX Ltd has demonstrated strong returns, with a 35.99% increase in the 1-year price total return as of the date provided. The company's stock is also trading near its 52-week high, at 97.08% of the peak, which may indicate market confidence in its current trajectory. According to an InvestingPro Tip, the company's management has been aggressively buying back shares, which can often be a sign of internal confidence in the stock's value and prospects.

Another InvestingPro Tip highlights that IBEX Ltd has a high shareholder yield, which, combined with the fact that the company does not pay a dividend, suggests that it may be returning value to shareholders through means other than dividends, such as share buybacks or debt reduction.

For those interested in further insights, there are additional InvestingPro Tips available that delve deeper into the company's financial health and stock performance. These tips can be accessed through the dedicated InvestingPro page for IBEX Ltd at https://www.investing.com/pro/IBEX.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Source: Investing.com